SCHEMBL18471981

SCHEMBL18471981

CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)Oc1cc(OC)cc(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.49
▸ CYP19A1 P11511 4/20 0.49
▸ MAPT P10636 4/20 0.49
▸ PPARG P37231 3/20 0.49
▸ OXER1 Q8TDS5 3/20 0.49
▸ RXRA P19793 2/20 0.49
▸ FFAR1 O14842 2/20 0.49
▸ EPHX2 P34913 3/20 0.45
▸ ADORA3 P0DMS8 2/20 0.45
▸ NR1I2 O75469 2/20 0.45
▸ PTGS2 P35354 2/20 0.45
▸ PGR P06401 1/20 0.45
▸ PDE4D Q08499 1/20 0.45
▸ CNR1 P21554 4/20 0.44
▸ FAAH O00519 2/20 0.44
▸ CYP3A4 P08684 2/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18471974 0.94 ALDH1A1 (0.44) ALDH1A1CYP19A1MAPTPPARGOXER1
SCHEMBL17212393 0.94 ALDH1A1 (0.55) ALDH1A1CYP19A1MAPTPPARGOXER1
SCHEMBL18471982 0.89 ALDH1A1 (0.50) ALDH1A1CYP19A1MAPTPPARGOXER1
SCHEMBL17212394 0.88 ALDH1A1 (0.49) ALDH1A1CYP19A1MAPTPPARGOXER1
SCHEMBL18471979 0.85 ALDH1A1 (0.49) ALDH1A1CYP19A1MAPTPPARGOXER1
SCHEMBL18471976 0.84 ALDH1A1 (0.45) ALDH1A1CYP19A1MAPTPPARGOXER1
SCHEMBL18487106 0.83 ALDH1A1 (0.44) ALDH1A1CYP19A1MAPTPPARGOXER1
SCHEMBL18471985 0.81 ALDH1A1 (0.42) ALDH1A1CYP19A1MAPTPPARGOXER1
SCHEMBL18471987 0.80 ALDH1A1 (0.44) ALDH1A1CYP19A1MAPTPPARGOXER1
SCHEMBL17212386 0.80 ALDH1A1 (0.44) ALDH1A1CYP19A1MAPTPPARGOXER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11014947-B2 Lipophenol compounds and uses thereof INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2021-05-25 — — US disclosed
US-10011620-B2 Lipophenol compounds and uses thereof INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2018-07-03 — — US disclosed
US-10011620-B2 Lipophenol compounds and uses thereof INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2018-07-03 — — US disclosed
US-20170037067-A1 NEW LIPOPHENOL COMPOUNDS AND USES THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2017-02-09 — — US disclosed
US-20170037067-A1 NEW LIPOPHENOL COMPOUNDS AND USES THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2017-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11014947-B2 Lipophenol compounds and uses thereof LPO, CBR1, LCLAT1 ALDH1A1 121/4885CYP19A1 948/4885MAPT 4789/4885
US-20170037067-A1 NEW LIPOPHENOL COMPOUNDS AND USES THEREOF LCLAT1, CBR1, LPO ALDH1A1 106/4885CYP19A1 1020/4885MAPT 4769/4885
US-10011620-B2 Lipophenol compounds and uses thereof LPO, CBR1, LCLAT1 ALDH1A1 121/4885CYP19A1 948/4885MAPT 4789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback